NicholasLHartogMD

PubMed

• 1 citations
  Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensu...
  Matthew Greenhawt, Timothy E Dribin, Elissa M Abrams, Marcus Shaker, Derek K Chu, David B K Golden, Cem Akin, Akterini Anagnostou, Faisal ALMuhizi, Waleed Alqurashi, P...> ;The Journal of Allergy and Clinical Immunology. 2023 Aug 1
• 3 citations
  Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency.
  Nicholas Hartog, Michael Hershfield, Thomas Michniacki, Shawn Moloney, Amanda Holsworth, Isabel Hurden, Mary Fredrickson, Mary Kleyn, Kelly Walkovich, Elizabeth Secord> ;Annals of Allergy, Asthma & Immunology. 2022 Dec 1
• 2 citations
  Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID).
  Elizabeth Secord, Nicholas L Hartog> ;Therapeutics and Clinical Risk Management. 2022 Jan 1
• 1 citations
  Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction.
  Jacqueline Eastman, Theodore Kelbel, Amanda Holsworth, Timothy Pebbles, Nicholas Hartog> ;Annals of Allergy, Asthma & Immunology. 2021 Oct 23
• 1 citations
  A single center experience of treating 19 patients with chronic cold urticaria
  Patricia Choi, Lisa Heyboer, Amanda Holsworth, Nicholas L. Hartog> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Jul 16
• 8 citations
  Balancing precision versus cohort transcriptomic analysis of acute and recovery phase of viral bronchiolitis.
  Ruchir Gupta, Mara L. Leimanis, Marie Adams, André S. Bachmann, Katie L. Uhl, Caleb Bupp, Nicholas L. Hartog, Eric J. Kort, Rosemary Olivero, Sarah S. Comstock, Domini...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2021 Apr 14
• 6 citations
  SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics.
  Nicholas L. Hartog, William Faber, Austin Frisch, Jacob Bauss, Caleb Bupp, Surender Rajasekaran, Jeremy W. Prokop> ;Expert Review of Proteomics. 2021 Apr 5
• Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.
  Nicholas L. Hartog, Amanda Holsworth, Surender Rajasekaran> ;Annals of Allergy, Asthma & Immunology. 2021 Feb 1
• 5 citations
  CCR5 and Biological Complexity: The Need for Data Integration and Educational Materials to Address Genetic/Biological Reductionism at the Interface of Ethical, Legal, ...
  Jacob Bauss, Michele Morris, Rama Shankar, Rosemary Olivero, Leah N Buck, Cynthia L Stenger, David Hinds, Joshua Mills, Alexandra Eby, Joseph W Zagorski, Caitlin Smith...> ;Frontiers in Immunology. 2021 Jan 1
• 18 citations
  High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
  Jeremy W. Prokop, Nicholas L. Hartog, Dave Chesla, William Faber, Chanise P Love, Rachid Karam, Nelly Abualkheir, Benjamin Feldmann, Li Teng, Tamara McBride, Mara Leim...> ;Frontiers in Immunology. 2021 Jan 1
• 3 citations
  Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab.
  Nicholas L. Hartog, Alan T. Davis, Jeremy W. Prokop, Andrew Walls, Surender Rajasekaran> ;Annals of Allergy, Asthma & Immunology. 2021 Mar 1
• 4 citations
  WD Repeat Domain 1 (WDR1) Deficiency Presenting as a Cause of Infantile Inflammatory Bowel Disease
  Jenna Millstead, Aarti Kamat, Ulrich A. Duffner, Aly Abdel-Mageed, Peter Freswick, David S. Dickens, Jennifer Stumph, Jeremy W. Prokop, Nicholas L. Hartog> ;Journal of Pediatric Gastroenterology and Nutrition. 2020 Oct 1
• 4 citations
  Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease
  Benjamin T Prince, Beth K Thielen, Kelli W. Williams, Erinn S. Kellner, Danielle E. Arnold, Wilfredo Cosme-Blanco, Margaret Redmond, Nicholas L. Hartog, Hey J Chong, S...> ;Pediatric Health, Medicine and Therapeutics. 2020 Jul 22
• 11 citations
  SARS-CoV-2 encoded proteome and human genetics: from interaction-based to ribosomal biology impact on disease and risk processes
  Olivia Sirpilla, Jacob Bauss, Ruchir Gupta, Adam Underwood, Dinah Qutob, Tom Freeland, Caleb Bupp, Joseph A. Carcillo, Nicholas L. Hartog, Surender Rajasekaran, Jeremy...> ;Journal of Proteome Research. 2020 Aug 10
• 26 citations
  A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services.
  Daniel A. Searing, Cullen M. Dutmer, David Fleischer, Marcus Shaker, John Oppenheimer, Mitchell H. Grayson, David R. Stukus, Nicholas Hartog, Elena W Y Hsieh, Nicholas...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2020 Jul 1
• 17 citations
  Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure
  Kevin R. Murphy, Bradley E. Chipps, David A. Beuther, Robert A. Wise, William McCann, Ileen Gilbert, James M. Eudicone, H. Gandhi, Gale Harding, Karin S. Coyne, Robert...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2020 Jul 1
• 26 citations
  Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency.
  Panojot Bifsha, Jennifer W. Leiding, Sung-Yun Pai, Aurelien B. L. Colamartino, Nicholas L. Hartog, Joseph A. Church, Benjamin Oshrine, Jennifer M. Puck, M. Louise Mark...> ;Blood Advances. 2020 Jun 23
• 55 citations
  Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia
  Marita Bosticardo, Francesca Pala, Enrica Calzoni, Ottavia M. Delmonte, Kerry Dobbs, Cameron L. Gardner, Nicolò Sacchetti, Tomoki Kawai, Elizabeth Garabedian, Debbie D...> ;Blood Advances. 2020 Jun 23
• 15 citations
  Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Physiological Genomics. 2020 Jun 1
• 215 citations
  COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.
  Marcus Shaker, John Oppenheimer, Mitchell H. Grayson, David R. Stukus, Nicholas Hartog, Elena W Y Hsieh, Nicholas L. Rider, Cullen M. Dutmer, Timothy K. Vander Leek, H...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2020 Mar 26
• 49 citations
  Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function
  Gillian I. Rice, Sehoon Park, Francesco Gavazzi, Laura Adang, Loveline A Ayuk, Lien Van Eyck, Luis Seabra, Christophe Barrea, Roberta Battini, Alexandre Belot, Stefan ...> ;Human Mutation. 2020 Jan 3
• 5 citations
  NAPDH Oxidase-Specific Flow Cytometry Allows for Rapid Genetic Triage and Classification of Novel Variants in Chronic Granulomatous Disease.
  Keith Sacco, Matthew J. Smith, Sami L. Bahna, David Buchbinder, Joshua G Burkhardt, Megan A. Cooper, Nicholas L. Hartog, Lisa Kobrynski, Kiran Patel, Roshini S. Abraham> ;Journal of Clinical Immunology. 2020 Jan 1
• 1 citations
  Institution of clinic scheduling guidelines for early introduction of peanut in high risk infants.
  Theodore E. Kelbel, Andrew Kampfschulte, Nicholas L. Hartog> ;Annals of Allergy, Asthma & Immunology. 2019 Sep 12
• 44 citations
  Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis
  Marita Bosticardo, Yasuhiro Yamazaki, Jennifer E. Cowan, Giuliana Giardino, Cristina Corsino, Giulia Scalia, Rosaria Prencipe, Melanie A. Ruffner, David A. Hill, Inga ...> ;American Journal of Human Genetics. 2019 Sep 5
• "The State of the Union": Current and Future Perspectives on Patient-Centric Care for Primary Immunodeficiencies and Immune Dysregulatory Diseases.
  Nicholas L. Hartog, Kelli W. Williams, Roshini S. Abraham> ;Frontiers in Immunology. 2019 Jul 26
• Join now to see all